Atopic allergy is the most common chronic disease among children in the developed world. This high prevalence could be associated with low microbial exposure. The early gut microbiota appears to be important for immune maturation. Immunomodulatory components in human milk might differ between mothers and could therefore explain the contradictory results seen regarding breastfeeding and allergy development. The aim of this thesis was to investigate whether early colonization with certain gut microbiota species influences childhood immune responses and allergy development up to age five. Also, as human milk oligosaccharides (HMOs) might stimulate the growth of certain gut microbiota species, the consumption of neutral colostrum HMOs was investigated for their role in allergy development up to 18 months. The concentrations of neutral colostrum HMOs varied considerably between women; however this variation could not be explained by their allergic status. Neither was the consumption of neutral colostrum HMOs related to allergy development in their children up to 18 months. Infants who harboured lactobacilli group I and Bifidobacterium adolescentis one week after birth developed allergic disease less frequently during their first five years than infants who did not harbour these bacteria at the same time. Also, colonization with several Bifidobacterium species was associated with higher levels of house dust endotoxin and larger family size. The early Bifidobacterium flora influenced levels of salivary secretory IgA at six and 12 months but not during later childhood. Moreover, the intensity of early Bacteroides fragilis colonization was inversely associated with spontaneous Toll-like receptor 4 mRNA expression in peripheral blood cells collected 12 months after birth. In conclusion, these results indicate that the early infant gut microbiota influences systemic and mucosal immune maturation during infancy, and that it might be altered in infants developing allergic disease.

Em nosso estudo foi avaliada a presença das bactérias do grupo Bacteroides fragilis em 108 amostras fecais de bezerros com e sem diarréia, além de fatores de virulência e a similaridade genética entre as cepas de B. fragilis. Hemolisinas foram observadas em 36,3% e em 83,7% dos bezerros com e sem diarréia, respectivamente. Apenas 7,4% dos isolados foram hemaglutinantes. De todos os isolados, grande parte resistiu à ação do soro e 100% foram sensíveis ao imipenem e metronidazol. Houve resistência aos metais pesados utilizados. Plasmídios foram detectados em 7,4% dos isolados. Dentre 58,8% produtores de ß-lactamase, em 19,7% e em 26,0% de bezerros com e sem diarréia, respectivamente detectou-se o gene cepA, que foi observado também em plasmídios de 5,5 kb. O gene cfiA foi observado em 16,5% dos isolados diarréicos e em 12,6% de não diarréicos, mas não em plasmídios. O gene nanH foi detectado em 21,8% dos isolados e o gene bft somente em dois isolados diarréicos. A similaridadade genética entre os B. fragilis mostrou a heterogeneidade das bactérias. / In this study the bacteria of Bacteroides fragilis group was evaluated in 108 fecal samples of calves with and without diarrhea, besides virulence factors and the genetic similarity among the B. fragilis strains. Hemolysin was observed in 36.3% and in 83.7% of calves with and without diarrhea, respectively. Only 7.4% of the isolates showed hemagglutinability. Of all the isolates, the major part resisted to the action of the serum and 100% were sensitive to the imipenem and metronidazole. There was resistance to the used heavy metals. Plasmids were detected in 7.4% isolates. Among 58.8% ß- lactamase producing, 19.7% and 26.0% strains of calves with and without diarrhea, respectively the cepA gene was detected, that was also observed in 5.5 kb plasmids. The cfiA gene was observed in 16.5% of the diarrheic isolates and 12.6% of non-diarrheic, but not in plasmids. The nanH gene was detected in 21.8% of the isolates and the bft gene only in two diarrheic isolates. The genetic similarity among the B. fragilis showed the heterogeneity of the bacteria.